Engitix, a British BioTech company tarobtaining the extracellular matrix (ECM) to develop transformative therapies for cancer and fibrosis, today announced…
Read More

Engitix, a British BioTech company tarobtaining the extracellular matrix (ECM) to develop transformative therapies for cancer and fibrosis, today announced…
Read More